BIOCARE HOLDINGS, LLC

Biocare Medical is a clinical pathology company specializing in immunohistochemistry (IHC), in situ hybridization (ISH), and fluorescence in situ hybridization (FISH) solutions for diagnostic and research laboratories. The company designs and manufactures an integrated platform of advanced staining instruments and over 300 optimized antibodies. Core product lines include the NeoPATH Pro, ONCORE Pro X, intelliPATH+, and intelliPATH MAX staining instruments, complemented by proprietary detection systems (MACH 4, MACH 3, MACH 2, MACH 1), multiplex IHC detection kits, and ancillary reagents (antigen retrieval solutions, enzymes, blocking reagents, mounting media, and wash buffers). The company also offers primary antibodies for various tissue types, FISH probes with copy control capabilities, RISH (RNA in situ hybridization) products, and animal tissue detection systems (PromARK). Biocare serves 50+ countries and maintains placements in over 1,000 clinical laboratories, including 95% of the top 50 cancer centers in the US. The company holds ISO 13485 certification and IVDR (In Vitro Diagnostic Regulation) certification for European markets. Technical support is available 24/7; customer service operates 6:30 AM–5:00 PM PST. Biocare was acquired by Agilent in 2024.